Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
Mehta brings extensive leadership and commercial expertise in biopharmaceutical, life science research, and diagnostics markets to Bio-Rad. He joins from Labcorp, where he served as Senior Vice President, overseeing large-scale commercial operations for the company's West Division. Prior to Labcorp, Mehta was Vice President and General Manager, Applied Technologies, at Thermo Fisher Scientific. In this role, he successfully managed a global business unit serving diverse markets. Earlier in his career, Mehta held commercial roles of increasing responsibility at Dow Chemical, where he designed and executed impactful commercial growth strategies. He holds an MBA from The Wharton School at the University of Pennsylvania and a BS in Electrical Engineering from Kurkshetra University in Thanesar, India.
"Rajat's proven track record in delivering above-market growth, building high-achieving teams, and driving alignment across multiple business segments will be instrumental as we continue to advance our long-term strategy,' said Jon DiVincenzo, Bio-Rad's President and Chief Operating Officer. 'His focus on commercial excellence and deep understanding of large, global organizations spanning both clinical diagnostics and life science markets make him a fantastic addition to our leadership team."
Norman Schwartz, Bio-Rad's Chairman and CEO, added, "On behalf of everyone at Bio-Rad, I want to extend our deepest gratitude and acknowledgement to Mike Crowley for his exceptional service and unwavering dedication. Since joining our commercial team in 1998, and particularly during his tenure as EVP of Global Commercial Operations since 2014, Mike's leadership has been instrumental in building our global sales and services organization and contributing to Bio-Rad's overall success.'
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
Forward-Looking Statements
This release may be deemed to contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements we make regarding our executive officers. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "plan", "believe," "expect," "anticipate," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions, although not all forward-looking statements contain these words. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. These risks and uncertainties include risks relating to our international operations; global economic and geopolitical conditions; tariffs or other trade barriers; reductions in government funding or capital spending of our customers; the uncertain pace of the biopharma sector's recovery; international legal and regulatory risks; our ability to develop and market new or improved products; our ability to compete effectively; foreign currency exchange fluctuations; supply chain issues; product quality and liability issues; our ability to integrate acquired companies, products or technologies into our company successfully; changes in the healthcare industry; and natural disasters and other catastrophic events beyond our control. For further information regarding our risks and uncertainties, please refer to the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operation" in Bio-Rad's public reports filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Bio-Rad cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
18 minutes ago
- Globe and Mail
Amazon Q2 Earnings Beat Estimates, Shares Dip: ETFs in Focus
Amazon AMZN reported stronger-than-expected second-quarter 2025 results. The online behemoth outpaced earnings and revenue estimates but offered a muted third-quarter operating income guidance. The guidance spooked investors who are eager to see Amazon's hefty investments in artificial intelligence pay off, pushing shares of AMZN down more than 8% in pre-market trading. This has put ETFs with a substantial allocation to this online behemoth in focus. These include Global X PureCap MSCI Consumer Discretionary ETF GXPD, Fidelity MSCI Consumer Discretionary Index ETF FDIS, ProShares Online Retail ETF ONLN, Vanguard Consumer Discretionary ETF VCR and Consumer Discretionary Select Sector SPDR Fund XLY. The e-commerce giant reported earnings per share of $1.68, outpacing the Zacks Consensus Estimate of $1.33 and the year-ago earnings of $1.23. Revenues grew 13% year over year to $167.7 billion and edged past the consensus estimate of $162.3 billion. Amazon's advertising business was its fastest-growing division in the quarter. Ad revenues increased 23% year over year to $15.69 billion. Online store sales grew 11% to $61.48 billion, while Amazon's cloud computing business — Amazon Web Services ('AWS') — revenues soared 17.5% year over year to $30.9 billion (read: 5 ETFs to Profit From Amazon's Longest-Ever Prime Day Event). Like other tech companies, Amazon has ramped up investments in data centers, chips and the power needed for AI workloads. The online giant has committed to spending up to $100 billion this year on AI as it races to build out data centers and software. It is also investing in its own computer chips and those developed by NVIDIA NVDA. The world's largest online retailer expects revenues in the range of $174-$179.5 billion for the third quarter of 2025. The Zacks Consensus Estimate is pegged at $173.13 billion. Amazon expects operating income of $15.5-$20.5 billion in the third quarter, below analysts' expectations. ETFs to Buy Global X PureCap MSCI Consumer Discretionary ETF (GXPD) Global X PureCap MSCI Consumer Discretionary ETF seeks to provide uncapped, market capitalization exposure to the Consumer Discretionary sector by tracking the MSCI USA Consumer Discretionary Index. It holds 50 stocks in its basket with Amazon occupying the top position at 38.3% of the assets. Global X PureCap MSCI Consumer Discretionary ETF has accumulated $0.5 million in its asset base since its debut last week and charges 0.15%. Fidelity MSCI Consumer Discretionary Index ETF (FDIS) Fidelity MSCI Consumer Discretionary Index ETF tracks the MSCI USA IMI Consumer Discretionary Index, holding 259 stocks in its basket. Of these, Amazon takes the top spot with a 24.2% share. Fidelity MSCI Consumer Discretionary Index ETF has amassed $1.8 billion in its asset base while trading in a good volume of around 86,000 shares a day on average. It charges 8 bps in annual fees from investors and currently has a Zacks ETF Rank #5 (Strong Sell) with a Medium risk outlook. ProShares Online Retail ETF (ONLN) ProShares Online Retail ETF offers exposure to companies that principally sell online or through other non-store channels and then zeroes in on the companies that reshape the retail space. It tracks the ProShares Online Retail Index, holding 19 stocks in its basket. Amazon is the top firm, accounting for 24% of the portfolio. ProShares Online Retail ETF has amassed $79 million in its asset base and currently trades in a moderate volume of around 8,000 shares a day on average. It charges 58 bps in annual fees from investors. Vanguard Consumer Discretionary ETF (VCR) Vanguard Consumer Discretionary ETF currently follows the MSCI US Investable Market Consumer Discretionary 25/50 Index and holds 296 stocks in its basket. Of these, Amazon occupies the top position, with a 23.9% allocation. Broadline Retail takes the largest share at 27%, while automobile manufacturers, restaurants and hotels, and resorts & cruise lines round off the next three spots. VCR charges investors 9 bps in annual fees, while volume is moderate at nearly 42,000 shares a day. The product has managed about $6.2 billion in its asset base and currently carries a Zacks ETF Rank #3 (Hold) with a Medium risk outlook (read: ETFs to Consider as Consumer Sentiment Improves in July). Consumer Discretionary Select Sector SPDR Fund (XLY) Consumer Discretionary Select Sector SPDR Fund offers exposure to the broad consumer discretionary space by tracking the Consumer Discretionary Select Sector Index. It is the largest and most popular product in this space, with AUM of nearly $22.5 billion and an average daily volume of around 5.1 million shares. Holding 51 securities in its basket, Amazon takes the top spot with 24.4% of the assets. Hotels, restaurants & leisure, broadline retail, specialty retail and automobiles are the top four sectors with double-digit exposure each. Consumer Discretionary Select Sector SPDR Fund charges 8 bps in annual fees and has a Zacks ETF Rank #3 with a Medium risk outlook. Boost Your Portfolio with Our Top ETF Insights Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week. Don't miss out on this valuable resource. It's free! Get it now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN): Free Stock Analysis Report NVIDIA Corporation (NVDA): Free Stock Analysis Report ProShares Online Retail ETF (ONLN): ETF Research Reports
Globe and Mail
18 minutes ago
- Globe and Mail
FLR Investors Have Opportunity to Join Fluor Corporation Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fluor Corporation ('Fluor' or 'the Company') (NYSE: FLR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Fluor reported its Q2 financial results and lowered its full-year guidance on August 1, 2025. The Company blamed its lackluster performance on growing costs in multiple infrastructure projects due to subcontractor design errors, price increases, and scheduling delays. The Company also claimed that customers are reducing capital spending. The Company failed to disclose these issues during prior affirmations of its full-year guidance. Based on this news, shares of Fluor fell by more than 30.5% in morning trading on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CTV News
18 minutes ago
- CTV News
What is the de minimis exemption and its big impact on small businesses
The words 'de minimis exemption' may not be familiar to all Canadians, but the American government's move to scrap that tariff exemption for low-value parcels may have a significant impact on small businesses across this country. The exemption excludes duty on shipments of goods into the U.S. that ar e evaluated to be worth US$800 or less, but an executive order signed by U.S. President Donald Trump Wednesday will scrap that provision. 'I am super worried about the logistics and costs of this,' says Tamara Bavdek, founder of Montreal-based jewelry company, 'This Ilk,' which she started sixteen years ago. She works in her home studio with vintage lace to fabricate statement pieces including earrings and necklaces sold online, including on Etsy. She ships her unique works of art internationally, but about a third of her business is now with the U.S. 'The words (de minimis exemption) was not part of my vocabulary until Trump started bringing in tariffs,' says Bavdek. 'But I was familiar with the provision. It made a lot of sense that for shipments under a certain amount there was no duty.' De minimis is Latin for 'lacking significance or importance, so minor as to merit disregard.' That disregard, says Bavdek, opened the door to simple small business dealings. The exemption was introduced in 1938, and now, more than 4 million de minimis packages enter the U.S. daily. 'It was mainly put in place because of the burden that it put on to the U.S. border and customs agencies and they, they just wanted to move things through quickly without having to deal with all of the paperwork and filings that were involved for small value packages,' says University of British Columbia Samuel Roscoe. Roscoe explained to Bavdek what the impact of lifting that exemption could be on her business and others across Canada. 'Your $100 shipment would be taxed and duty at the same rate as a $2,000 shipment. So, you're basically going to be paying whatever, rate that is agreed on between Canada and the United States,' he said. With tight margins for small and medium enterprise owners, that hike in the cost of doing business is likely to be passed on to consumers. But what is also likely to be a concern are the logistics of switching over to a new system. 'I'm sending one package at a time to customers, and if I'm filling out a form every time… I don't even know where I'm supposed to find this form,' says Bavdek.' I don't know if my packages can get stuck. I don't know what kind of delays I can tell my customers to expect. This is super worrisome to me.' Roscoe considers this an additional barrier, adding that the change is creating a whole new industry of paperwork that businesses will have to fill out. It will also lead to delays as all international shipments coming into the United States will have to go through a documentation and custom clearance process. 'I pretty much guarantee you there is going to be delays, for, for shipments into the States as a direct result of this,' says Roscoe. 'I wish I could give you some more good news Tamara, but unfortunately, I think, Trump seems to be making, as difficult as possible to do business with US customers at the moment,' he told Bavdek on a Zoom call. Both say they hope Canadians will once again hear the message that it is important to support local businesses that may struggle because of this change. Trump had earlier taken aim at packages shipped from China and Hong Kong, but the applicable duties will kick in for countries around the world as of Aug. 29.
